Effects of non-heavy smoking on high-density lipoprotein cholesterol in healthy Turkish young men

Acta Cardiologica

Volumn 61, Issue 4, 2006, Pages 411-415

  Barcin, Cem ^a,c   Tapan, Serkan ^a   Kursaklioglu, Hurkan ^b   Iyisoy, Atila ^b   Olcay, Ayhan ^a   Erbil, M Kemal ^b   Isik, Ersoy ^b  

^a Ankara Gendarmarie Hospital   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

^c Kardiyoloji Servisi   (Turkey)

Author keywords

Coronary risk; HDL cholesterol; Smoking

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; BLOOD SAMPLING; BODY MASS; CIGARETTE SMOKING; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; QUESTIONNAIRE; SMOKING; SYSTOLIC BLOOD PRESSURE; TURKEY (REPUBLIC); WAIST HIP RATIO;

ADULT; ALCOHOL DRINKING; CHOLESTEROL, HDL; CORONARY DISEASE; HUMANS; MALE; RISK FACTORS; SMOKING; TURKEY;

EID: 33748430636     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.61.4.2017301     Document Type: Article

References (23)

1. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, Jacobs DR Jr, Bangdiwala S, Tyroler HA. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989; 79: 8-15.
2. Wilson PW, Abbott RD, Castelli WP. High density lipoprotein cholesterol and mortality: the Framingham Heart Study. Arteriosclerosis 1988; 8: 737-41.
3. Jacobs DR Jr, Mebane IL, Bangdiwala SI, Criqui MH, Tyroler HA. High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study. Am J Epidemiol 1990; 131: 32-47.
4. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 1977; 62: 707-14.
5. Albucher JF, Ferneres J, Ruidavets JB, Guiraud-Chaumeil B, Perret BP, Chollet F. Serum lipids in young patients with ischaemic stroke: a case-control study. J Neurol Neurosurg Psychiatry 2000; 69: 29-33.
6. Soyama Y, Miura K, Morikawa Y, Nishijo M, Nakanishi Y, Naruse Y, Kagamimori, Nakagawa H; Oyabe Study. High-density lipoprotein cholesterol and risk of stroke in Japanese men and women: the Oyabe Study. Stroke 2003; 34: 863-8.
7. Packard C, Nunn A, Hobbs R. High density lipoprotein: Guardian of the vascular system? Int J Clin Pract 2002; 56: 761-71.
8. Bersot T, Pepin GM, Mahley RW. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol. Am Heart J 2003; 146: 1052-60.
9. Ellison RC, Zhang Y, Qureshi MM, Knox S, Arnett DK, Province MA for the Investigators of the NHLBI Family Heart Study. Lifestyle determinants of high-density lipoprotein cholesterol: The National Heart, Lung, and Blood Institute Family Heart Study. Am Heart J 2004; 147: 529-35.
10. Kesteloot H, Geboers J, Joossens JV. On the within-population relationship between nutrition and serum lipids: the B.I.R.N.H. study. Eur Heart J 1989; 10: 196-202.
11. Rubins HB, Robins SJ, Collins D, Iranmanesh A, Wilt TJ, Mann D, Mayo-Smith M, Faas FH, Elam MB, Rutan GH et al. Distribution of lipids in 8,500 men with coronary artery disease. Department of Veterans Affairs HDL Intervention Trial Study Group. Am J Cardiol 1995; 75: 1196-201.
12. The Expert Panel. The Third Report of National Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. (Adult Treatment Panel III). Final Report. Circulation 2002; 106: 3143-421.
13. Yamamoto A, Temba H, Horibe H, Mabuchi H, Saito Y, Matsuzawa Y, Kita T, Nakamura H; Research Group on Serum Lipid Survey 1990 in Japan. Life style and cardiovascular risk factors in the Japanese population-from an epidemiological survey on serum lipid levels in Japan 1990 part 1: influence of life style and excess body weight on HDL-cholesterol and other lipid parameters in men. J Atheroscler Thromb 2003; 10: 165-75.
14. Wu DM, Pai L, Sung PK, Hsu LL, Sun CA. Joint effects of alcohol consumption and cigarette smoking on atherogenic lipid and lipoprotein profiles: results from a study of Chinese male population in Taiwan. Eur J Epidemiol 2001; 17: 629-35.
15. Freeman DJ, Packard CJ. Smoking and plasma lipoprotein metabolism. Clin Sci (Lond) 1995; 89: 333-42.
16. Kong C, Nimmo L, Elatrozy T, Anyaoku V, Hughes C, Robinson S, Richmond W, Elkeles RS. Smoking is associated with increased hepatic lipase activity, insulin resistance, dyslipidaemia and early atherosclerosis in Type 2 diabetes. Atherosclerosis 2001; 156: 373-8.
17. Hughes K, Choo M, Kuperan P, Ong CN, Aw TC. Cardiovascular risk factors in relation to cigarette smoking: a population-based survey among Asians in Singapore. Atherosclerosis 1998; 137: 253-8.
18. Nakanishi N, Nakamura K, Ichikawa S, Suzuki K, Tatara K. Relationship between lifestyle and serum lipid and lipoprotein levels in middle-aged Japanese men. Eur J Epidemiol 1999; 15: 341-8.
19. Craig MH, Palomaki GE, Haddow JE. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. Br Med J 1989; 298: 784-8.
20. Mjos OD. Lipid effects of smoking. Am Heart J 1988; 115: 272-5.
21. Raftopoulos C, Bermingham MA, Steinbeck KS. Coronary heart disease risk factors in male adolescents, with particular reference to smoking and blood lipids. J Adolesc Health 1999; 25: 68-74.
22. Maeda K, Noguchi Y, Fukui T. The effects of cessation from cigarette smoking on the lipid and lipoprotein profiles: a meta-analysis. Prev Med 2003; 37: 283-90.
23. Molarius A, Seidell JC, Kuulasmaa K, Dobson AJ, Sans S. Smoking and relative body weight: an international perspective from the WHO MONICA Project. J Epidemiol Community Health 1997; 51: 252-60.